Eccentric Manual Resistance Training in Patients With Ischemic CMP

April 30, 2024 updated by: Walter Bily, MD, Vienna Hospital Association

Eccentric Manual Resistance Training for Improvement of Strength and Function in Patients With Ischemic Cardiomyopathy and Mildly Reduced Ejection Fraction

Patients with ischemic cardiomyopathy and mildly reduced ejection fraction suffer from reduced functional capacity and fatigue caused by loss of muscle strength and reduced aerobic capacity.

A few studies have shown that structured endurance and resistance training programs were able to improve walking capacity and limb strength.

Although both concentric and eccentric training programs are beneficial for these patients, eccentric training is less stressful to the cardiovascular system.

The aim of the study is to determine if eccentric-orientated body weight and manual resistance training in ischemic cardiomyopathy patients will lead to superior results compared to concentric training.

Study Overview

Detailed Description

BACKGROUND: Eccentric resistance training demonstrated positive effects in ischemic cardiomyopathy patients in several studies. These studies were mainly set on device-based training interventions comparing eccentric-orientated and concentric-orientated training. Eccentric-orientated training induced comparable positive effects on cardiac and functional levels and even better effects on muscle strength improvement.

RESEARCH AIMS: The aim of the study is to determine if eccentric-orientated body weight and manual resistance training in ischemic cardiomyopathy patients will allow a more significant improvement in maximum voluntary contraction force of the knee extensors compared to concentric training.

In contrast to previous studies, these interventions will be set without use of training devices.

In addition, changes in the muscle cross section of the quadriceps muscle will be calculated by skeletal muscle ultrasound. Functional changes and quality of life will be assessed using one minute sit to stand test, six minutes walking test and Kansas City Cardiomyopathy Questionnaire. Cardiac outcome parameters will be assessed by using body composition and hemodynamic parameters as well as echocardiography, laboratory values and specific biomarkers for sarcopenia / cachexia.

METHODS: The investigators propose to run a monocentric, prospective, double arm, open, randomized controlled trial. Eccentric-orientated training will be delivered to 30 ischemic cardiomyopathy patients.

These patients will be randomized into two groups at the beginning, followed by a 6-weeks observation phase (without intervention for internal quality control of the measurement parameters). The intervention-phase will consist of six weeks of three times weekly either eccentric or concentric-oriented training.

Outcome measurements will take place after randomization, after 6 weeks of observation as well as after the intervention phase

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, 1160
        • Klinik Ottakring

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male / female, 45-85a
  • Ischemic cardiomyopathy with mildly reduced ejection fraction (40 -50%)
  • Coronary heart disease

Exclusion Criteria:

  • Acute coronary syndrome, myocarditis or pericarditis in the last 3 months
  • Cardiac decompensation in the last 3 months
  • Severe symptomatic heart failure NYHA IV (New York Heart Association)
  • Device - carrier (ICD= Intracardial Defibrillator, CRT= Cardiac Resynchronization Therapy, PM=Pacemaker)
  • Hemodynamically significant valvular disease
  • Symptomatic cardiac arrhythmia
  • Intractable, uncontrolled hypertension (repetitive blood pressure > 150/100)
  • Severe comorbidities, which lead to study exclusion by the investigator
  • Pregnancy / nursing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Observation phase
After screening and randomization for either the eccentric orientated intervention group or the concentric orientated intervention group, all measurements will be made for the first time by investigators at point A1. An observational phase for six weeks will follow to achieve an intern acceptance sampling for the measurements which will be used.
Active Comparator: Eccentric training group

Subjects in the eccentric training group (GEC) will attend six weeks of eccentric orientated training. The eccentric orientated training will use the cadence 3-0-1 for eccentric - break - concentric.

  • 3 sessions/week
  • 60 minutes per session including a warming up and cool down phase
  • 6 exercises
  • total of 18 sessions
Eccentric bodyweight resistance training
Active Comparator: Concentric training group

The concentric training group (GCO) will attend six weeks of concentric orientated training. Each group will perform a manual resistance/bodyweight resistance training accentuating the concentric phase of the movement. The concentric orientated training will use the cadence 1-0-3 for eccentric - break - concentric.

  • 3 sessions/week
  • 60 minutes per session including a warming up and cool down phase
  • 6 exercises
  • total of 18 sessions
Concentric bodyweight resistance training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MVC of knee-extensors isometric
Time Frame: Baseline
Knee dynamometer
Baseline
MVC of knee-extensors isometric
Time Frame: After 6 weeks of observation
Knee dynamometer
After 6 weeks of observation
MVC of knee-extensors isometric
Time Frame: After 6 weeks of training
Knee dynamometer
After 6 weeks of training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement
Time Frame: Baseline
Sonographic measurement
Baseline
Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement
Time Frame: After 6 weeks of observation
Sonographic measurement
After 6 weeks of observation
Muscle cross section area of the quadriceps femoris muscle calculated by skeletal muscle ultrasound measurement
Time Frame: After 6 weeks of training
Sonographic measurement
After 6 weeks of training
Six- minutes walking test (6MWT)
Time Frame: Baseline
Measures the walking distance within 6 minutes.
Baseline
Six- minutes walking test (6MWT)
Time Frame: After 6 weeks of observation
Measures the walking distance within 6 minutes.
After 6 weeks of observation
Six- minutes walking test (6MWT)
Time Frame: After 6 weeks of training
Measures the walking distance within 6 minutes.
After 6 weeks of training
One-minute sit to stand test
Time Frame: Baseline
Measures sit to stand repetitions within one minute.
Baseline
One-minute sit to stand test
Time Frame: After 6 weeks of observation
Measures sit to stand repetitions within one minute.
After 6 weeks of observation
One-minute sit to stand test
Time Frame: After 6 weeks of training
Measures sit to stand repetitions within one minute.
After 6 weeks of training
Quality of life (QoL)
Time Frame: Baseline
Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
Baseline
Quality of life (QoL)
Time Frame: After 6 weeks of observation
Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
After 6 weeks of observation
Quality of life (QoL): questionnaire
Time Frame: After 6 weeks of training
Kansas City Cardiomyopathy questionnaire (KCCQ) In the KCCQ, an overall summary score can be derived from the physical function, symptom (frequency and severity), social function and quality of life domains. For each domain, the validity, reproducibility, responsiveness and interpretability have been independently established. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
After 6 weeks of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Walter Bily, MD, Vienna HA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 29, 2022

Primary Completion (Actual)

December 12, 2023

Study Completion (Actual)

December 12, 2023

Study Registration Dates

First Submitted

April 17, 2020

First Submitted That Met QC Criteria

March 31, 2021

First Posted (Actual)

April 2, 2021

Study Record Updates

Last Update Posted (Actual)

May 1, 2024

Last Update Submitted That Met QC Criteria

April 30, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Cardio eccentric protocol 3.5

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemic Cardiomyopathy

Clinical Trials on Eccentric manual resistance training

Subscribe